LOXL2 and hepatocellular carcinoma: Direct evidence on LOXL2-induced PMN formation was provided by pioneer work by Cui and colleagues, who demonstrated that matrix stiffness-upregulated LOXL2 promoted recruitment of bone marrow derived cells to assist pre-metastatic niche formation of hepatocellular carcinoma 53.